OVOL1 and cancer: By elucidating the molecular mechanism by which OVOL1 affects the progression of NSCLC through the cholesterol metabolism pathway, we can provide a novel therapeutic target for treating NSCLC by exploiting the vulnerability of cancer cells associated with metabolic reprogramming.